Earnings Tell The Story For Medexus Pharmaceuticals Inc. (TSE:MDP) As Its Stock Soars 28%
May 04
MDP Share Price Performance
MDP Community Fair Values
- AN
Consensus Narrative from 7 AnalystsUS Launch Of GRAFAPEX Will Provide Seven Years Of Exclusive Market Access
Key Takeaways FDA exclusivity for GRAFAPEX boosts revenue stability and reduces competitive pressure, enhancing margins. Strategic investments from public offering support GRAFAPEX's commercialization and drive future earnings growth.View narrativeCA$6.46FV56.1% undervalued intrinsic discount8.15%Revenue growth p.a.1users have liked this narrative0users have commented on this narrative8users have followed this narrative3 days ago author updated this narrative
